Senior researchers

Ángeles Álvarez Ribelles

Full professor, Department of Pharmacology, University of Valencia.
Since 2016: Permanent researcher staff, Department of Pharmacology, University of Valencia.
Since 2015: Associate professor, Faculty of Health Sciences, Universitat Jaume I, Castellón.
2007-present: Principal investigator of 3 research projects funded by the “Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia” of the Spanish Ministry of Economy, Industry and Competitiveness.
Since 2007: Member of a research group at the Center for Biomedical Research in the Hepatic and Digestive Diseases Network (CIBER), funded by the Spanish Ministry of Economy and Competitiveness.
Since 2014: Member of the Mixed Research Unit in Biomedicine FISABIO-Hospital Dr.Peset-UV-Universitat Jaume I.
2011-2016: Postdoctoral researcher, Fundación General de la Universitat de València.
2006-2011: Postdoctoral researcher. Ramón y Cajal Programme, Department of Pharmacology, University of Valencia/Centro Nacional de Investigaciones Cardiovasculares (CNIC).
2003-2005: Postdoctoral fellowship for an overseas stay at the Brigham and Women’s Hospital and Harvard Medical School, funded by the Spanish Ministry of Education and Science.
2002-2003: Postdoctoral researcher, Centro Nacional de Investigaciones Cardiovasculares (CNIC).
2002: Doctor in Pharmacy, University of Valencia. Best Thesis Award.
1997: Graduate in Pharmacy, University of Valencia.
Main fields of interest: vascular toxicity of antiretroviral therapy; physiopathological mechanisms implicated in the development of thrombi and other vascular diseases.

Isabel Andújar Pérez

Senior postdoctoral researcher.
2015-2018: Postdoctoral researcher, Sara Borrell Programme (Instituto de Salud Carlos III).
2012: PhD in Biomedicine and Pharmacy, University of Valencia. Best Thesis Award.
2008: Master in Research and Rational Drug Use, University of Valencia. Best Master Award.
2006: Graduate in Pharmacy, University of Valencia. Graduate Award.
Main fields of interest: antiretroviral toxicity and HIV; biological drugs and biosimilars.

Nadezda Apostolova

Lecturer, Department of Pharmacology, University of Valencia.
2013-2015: Lecturer, Faculty of Health Sciences, Jaume I University, Castellón.
2008-2013: Postdoctoral researcher, University of Valencia.
2008: Doctor in Pharmacology from University of Valencia.
2001: Graduate in Biological Sciences (speciality in Biochemistry) from University of Saints Cyril and Methodius, Macedonia.
Main fields of interest:mitochondrial dysfunction and it's role in pathogenesis; cellular mechanisms involved in the toxicity of antiretroviral drugs and HIV with special focus on mitochondrial function; endoplasmatic reticular stress and activation of survival programmes (autophagy) and cellular death (apoptosis).

María Dolores Barrachina Sancho

Full Professor of Pharmacology, University of Valencia.
2010-present: Principal Investigator of research projects funded by the "Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia" of the Ministry of Economy, Industry and Competitiveness.
2007-present: Member of a research group at Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERedh), a national network of research groups investigating liver and digestive diseases funded by the Spanish Ministry of Economy, Industry and Competitiveness.
Member of the Unidad Mixta de Investigación en Biomedicina FISABIO-Hospital Dr. Peset-UV-Universitat Jaume I.
Graduate and Doctor in Pharmacy from the University of Valencia. Best Thesis Prize.

Ana Blas García

2017-2019: Postdoctoral researcher, CIBERehd.
2016: Postdoctoral stay at Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid.
2015: Postdoctoral stay at Icahn School of Medicine at Mount Sinai Hospital, New York.
2014-2016: Postdoctoral researcher Juan de la Cierva (Ministerio de Economía y Competitividad).
2012: PhD in Biology, Universitat de València. Best Thesis Award.
2007: Advanced Studies Certificate (Master degree) in Molecular Biology and Genetics, Universitat de València.
2005: Graduate in Biology, Universitat de València.
Main fields of interest: HIV and antiretroviral-induced toxicities; liver fibrosis; non-alcoholic fatty liver disease.

Sara Calatayud Romero

Full professor of Pharmacology, University of Valencia.
2013 - present: Principal Investigator of research projects of the " Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia " of the Spanish Ministry of Economy, Industry and Competitiveness.
2007 - present: Member of a research group at the Center for Biomedical Research in the Hepatic and Digestive Diseases Network (CIBER), funded by the Spanish Ministry of Economy and Competitiveness.
2014 - present: Member of the Mixed Research Unit in Biomedicine FISABIO-Hospital Dr. Peset-UV-Universitat Jaume I.
Graduate and Doctor in Pharmacy from the University of Valencia.
Main fields of interest: basic research in inflammatory bowel disease;mechanisms of mucosal recovery and progression to fibrosis.

Víctor Collado Díaz

Ramón y Cajal research contract, Department of Pharmacology, University of Valencia.
2019-2023: Postdoctoral researcher and Lecturer, Institute of Pharmaceutical Sciences, Pharmaceutical Immunology, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland.
2014-2018: PhD Student, Digestive and Inflammatory Diseases Research Unit, Pharmacology Department, Faculty of Medicine and Odontology, University of Valencia.
2012-2013: Advanced Studies Certificate (Master’s Degree) in Pharmacological Research, Department of Pharmacology, University of Valencia.
2012: Graduate of Pharmacy with First Class Honours, Faculty of Pharmacy, University of Valencia, Spain.

Jesús Cosín Roger

2021-present: Doctor assistant lecturer of the Department of Pharmacology, University of Valencia.
2021-Miguel Servet Researcher.
2019-Associate lecturer at the Department of Animal Medicine and Surgery of the Faculty of Veterinary Medicine of Universidad Cardenal Herrera CEU.
2020: Postdoctoral researcher, Juan de la Cierva Incorporación Programme (Ministry of Science and Innovation).
2017-2020: Postdoctoral researcher, Sara Borrell Progamme, (Instituto de Salud Carlos III).
2016-2017: Postdoctoral Researcher in the laboratory of Prof.Gerhard Rogler, University Hospital Zurich. ECCO Fellowship.
PhD in Biomedicine and Pharmacy from the University of Valencia. Best Thesis Award.
Master in Biomedical Biotechnology from the Polytechnic University of Valencia.
Graduate in Biotechnology from the Polytechnic University of Valencia.
Member of the Sociedad Española de Farmacología (SEF).
Member of the European Crohn`s and Colitis Organisation (ECCO).
Main fields of interest: Intestinal Inflammatory Disease (IBD); intestinal fibrosis; Epithelial to Mesenchymal Transition (EMT); macrophages, fibroblasts, autophagy, hypoxia.

Dulce Carolina Macias Ceja

Senior postdoctoral researcher.
2018: Doctor in Biomedicine and Pharmacy from the University of Valencia.
2013-2014: Official Master’s Degree in Molecular Approaches in Health Sciences (University of Valencia). Final Master project in the Department of Food Technology at the Institute of Agrochemical and Food Technology (CSIC) titled “Proteomic analysis of flour toxic peptides: identification of antigliadin and R5 binding proteins with sequential extracts from wheat and rice”.
2011-2013: Lecturer and coordinator of undergraduate biology degree at the University of Colima, México.
2009-2011: Master´s Experimental Biology, University of Zacatecas, México.
2004-2009: University Degree in Biology, University of Colima, México.

Miguel Martí Cabrera

Full Professor of Pharmacology, Department of Pharmacology, University of Valencia.
2007-present: Member of a research group at the Centre for Biomedical Research in the Hepatic and Digestive Diseases Network (CIBERehd).
2014-present: Member of the FISABIO-Hospital Dr. Peset-UV-Universitat Jaume I Collaborative Biomedical Research Unit.
Graduate and Doctor in Medicine and Surgery from the University of Valencia.
Main fields of interest: mechanisms of the inflammatory response in endocrine/metabolic disorders and their pharmacological modification; pathologies of the digestive tract; toxicity of antiretroviral drugs.

María Ángeles Martínez Cuesta

Lecturer of Pharmacology, University of Valencia. Participant in several basic research projects about the cardiovascular toxicity of antiretroviral drugs.
2008-2009: PI of a precompetitive researcher project: statins and hypoxia.
1999-2003: Assistant Lecturer, Department of Pharmacology, University of Valencia. Participant in several research projects concerning gastrointestinal and cardiovascular inflammation.
1998-1999: Director of the Department of Pharmacology, Division of Pharmacological I+D, Laboratorios Lacer S.A. (Barcelona). Development of antithrombotic drugs.
1995-1997: NATO Postdoctoral Scholarship, Laboratory of Dr. Marek Radomski, University of Alberta, Canada. Cardiovascular and thrombosis research line.
1993: Doctor in Pharmacy from the University of Valencia. Best Thesis Prize.
1992-1994: Trainee researcher grant (Spanish Ministry of Education).
1991-1992: Postgraduate grant from the Fundación Juan Esplugues. Research stay at the Wellcome Research Laboratories (UK) under the direction of Dr. Brendan Whittle and Dr. Salvador Moncada.
1989: Graduate in Pharmacy from the University of Valencia.
Main fields of interest: new pro- and anti-thrombotic mechanisms.

María Dolores Ortiz Masià

Present: Lecturer, Department of Medicine, University of Valencia.
2014: Graduate in Medicine from the University of Valencia.
2007-2014: Postdoctoral researcher, CIBERehd.
2007: Doctor in Biochemistry and Molecular Biology from the University of Valencia. Doctoral thesis entitled "Functional characterization of C1 subgroup MAP kinases of plants" under the supervision of Dr. Fernando Aniento Company and Dr. María Jesús Marcote Zaragoza.
2003: M.S. in Biochemistry and Molecular Biology from the University of Valencia.
2001: Bachelor of Pharmacy from the University of Valencia.
Member of ECCO (European Crohn’s and Colitis Organization), CIBERehd (Centro de Investigaciones en Red, enfermedad hepática y digestiva) and SEPD (Sociedad Española de Patología Digestiva) membership.
Member of the Scientific Evaluation Committee of GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa).

Milagros Rocha Barajas

R3 Senior Researcher, FISABIO Fundation.
2011: Miguel ServetPhase II Researcher (Carlos III Health Institute).
2007-present: Member CIBERedh, a national network of research groups investigating liver and digestive diseases funded by the Spanish Central Government.
2010-2017: Member of a PROMETEO Research Group of Excellence, Regional Ministry of Education, Research, Culture and Sports.
2007: Senior research technician, Carlos III Health Institute.
2003: Doctor in Biological Sciences, Complutense University of Madrid.
1995: Graduate in Biological Sciences, Complutense University of Madrid.
Main areas of expertise: underlying mechanisms associated with the physiopathology of obesity and effect of weight loss; functional foods and insulin resistance.

Víctor Manuel Víctor

Lecturer of Physiology, University of Valencia.
Since 2011: Senior researcher at FISABIO-Hospital Dr Peset-University of Valencia.
Since 2008: Associated Professor, Department of Physiology, Faculty of Medicine, University of Valencia.
2008-2011: Miguel Servet postdoctoral researcher, FISABIO-Hospital Dr Peset.
2004-2008: Miguel Servet postdoctoral researcher, CNIC.
2002-2004: Postdoctoral researcher, CNIC.
2001: Doctor in Physiology from Complutense University of Madrid.
1995: Graduate in Biological Sciences from Complutense University of Madrid.
Main fields of interest: mitochondrial/endothelial dysfunction; endoplasmic reticulum stress; autophagy and inflammasome in cardiometabolic diseases such as type 2 diabetes.